Temozolomide: all 659 studies that test it
Page 6 of 7. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00768911Phase 1
- Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in ChildrenCompletedNCT00749723Phase 2/3
- Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaTerminatedNCT00734526Phase 1
- A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic MelanomaTerminatedNCT00724841Phase 1/2
- Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade GliomaCompletedNCT00720564Phase 1
- Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or TemozolomideCompletedNCT00717210Phase 3
- Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00714181Phase 1
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant GliomasCompletedNCT00704080Phase 1
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant GliomaCompletedNCT00687765Phase 1/2
- Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00662506Phase 1/2
- A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade GliomaStatus unknownNCT00660283Phase 2
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaCompletedNCT00650923Phase 1
- Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma PatientsStatus unknownNCT00643825Phase 2
- Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain TumorsCompletedNCT00639262Phase 1
- Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyTerminatedNCT00629187Phase 1
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryCompletedNCT00626015Phase 1
- Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideCompletedNCT00616005Phase 2
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody TherapyTerminatedNCT00615186Phase 3
- Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast CancerCompletedNCT00614978Phase 1
- Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant GliomaCompletedNCT00613093Phase 2
- Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBMCompletedNCT00612989Phase 1
- PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasCompletedNCT00612651Phase 1
- Ph I Oral Topotecan and Temozolomide for Patients With Malignant GliomasCompletedNCT00610571Phase 1
- Phase 1 Study of MPC-6827 and Temozolomide in Metastatic MelanomaCompletedNCT00609011Phase 1/2
- Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By SurgeryWithdrawnNCT00601614Phase 1
- Temozolomide in Treating Patients With Invasive Pituitary TumorsWithdrawnNCT00601289Phase 2
- Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00568048Phase 2
- Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBMTerminatedNCT00548938Phase 2
- Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain TumorsCompletedNCT00547131Phase 1
- Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentCompletedNCT00544284Phase 1
- Taxotere/Temodar/Cisplatin Study in Melanoma PatientsCompletedNCT00527761Phase 1
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma PatientsCompletedNCT00527657Phase 1
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsCompletedNCT00526617Phase 1
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent GlioblastomaStatus unknownNCT00521482Phase 2
- Enzastaurin and Temozolomide in Treating Patients With Primary GliomasStatus unknownNCT00516607Phase 1
- VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaTerminatedNCT00516282Phase 1
- DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisTerminatedNCT00515788Phase 1
- Temozolomide and Radiation Therapy in Treating Young Patients With Pontine GliomaStatus unknownNCT00514397Phase 2
- Dietary Methionine Restriction Plus Temozolomide for Recurrent GBMTerminatedNCT00508456Phase 1
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and CytarabineStatus unknownNCT00503594Phase 2
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasStatus unknownNCT00492687Phase 2
- Aerosol L9-NC and Temozolomide in Ewing's SarcomaCompletedNCT00492141Phase 1/2
- Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)CompletedNCT00481455Phase 2
- Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma MultiformeCompletedNCT00458601Phase 2
- a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
- Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00437957Phase 1
- A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCompletedNCT00422682Phase 1
- Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and AdolescentsCompletedNCT00412503Phase 1
- Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
- Docetaxel and Temozolomide in Treating Patients With Metastatic CancerCompletedNCT00401180Phase 1
- Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed OligoastrocytomaCompletedNCT00400816Phase 2
- AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00394628Phase 1/2
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00390403Phase 1
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTerminatedNCT00389090Phase 2
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
- PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic DrugsCompletedNCT00385853Phase 1
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Randomized Trial of ATN-224 and Temozolomide in Advanced MelanomaStatus unknownNCT00383851Phase 2
- Radiation Boost for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00376103Phase 1/2
- Phase II Study of Temozolomide in Newly Diagnosed GlioblastomaTerminatedNCT00365222Phase 2
- Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed OligoastrocytomaCompletedNCT00362570Phase 2
- Cisplatin and Temozolomide in Treating Young Patients With Malignant GliomaStatus unknownNCT00360945Phase 2
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaCompletedNCT00354068Phase 1
- Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)CompletedNCT00335075Phase 3
- Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00316849Phase 1
- Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)Status unknownNCT00311857Phase 1/2
- Temodar and Sutent as Therapy for MelanomaTerminatedNCT00304200Phase 1/2
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Radiation With Concomitant and Then Sequential Temozolomide in Malignant GliomaStatus unknownNCT00283543Phase 2
- Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory NeuroblastomaCompletedNCT00276679Phase 2
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryStatus unknownNCT00275067Phase 1/2
- Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00274833Phase 2
- A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With MelanomaTerminatedNCT00272415Phase 1
- Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLCStatus unknownNCT00268684Phase 3
- Vorinostat and Temozolomide in Treating Patients With Malignant GliomasActive, not recruitingNCT00268385Phase 1
- Safety and Efficacy of Talampanel in Glioblastoma MultiformeCompletedNCT00267592Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed GliomasCompletedNCT00253487Not applicable
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00238277Phase 2
- Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesCompletedNCT00238251Phase 2
- Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast CancerCompletedNCT00194766Phase 2
- Radiation Therapy or Temozolomide in Treating Patients With GliomasCompletedNCT00182819Phase 3
- Prolonged Daily Temozolomide for Low-Grade GliomaCompletedNCT00165360Phase 2
- Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsCompletedNCT00165230Phase 2
- Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and AdolescentsCompletedNCT00147160Phase 2
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
- Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine TumorsCompletedNCT00137774Phase 2
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00128700Phase 1/2
- Temozolomide and Topotecan in Treating Patients With Primary CNS LymphomaWithdrawnNCT00109798Not applicable
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00104988Phase 2
- Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideActive, not recruitingNCT00102648Phase 1
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00099125Phase 2
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory LeukemiasCompletedNCT00098436Phase 1
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
- Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00086879Phase 2
- Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial GliomasStatus unknownNCT00083096Phase 1
- Temozolomide in Treating Young Patients With Refractory or Recurrent LeukemiaCompletedNCT00083070Phase 1
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)CompletedNCT00076856Phase 2
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaCompletedNCT00072345Phase 2
- Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaCompletedNCT00072163Phase 2